We are live on ! Find out more
NSPR icon

InspireMD

4 hedge funds and large institutions have $55K invested in InspireMD in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.56% less ownership

Funds ownership: 4.5% → 0.93% (-3.6%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

60% less funds holding

Funds holding: 10 → 4 (-6)

89% less capital inflows, than outflows

Capital inflows: $24.8K | Capital outflows: $230K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
4
Holders Change
-6
Holders Change %
-60%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

NSPR Hedge Fund Activity: Q1 2019 in Review

4 of the 4,634 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q1 2019, worth a combined $55K — down 80% from $269K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of NSPR and 0 opened new positions — a net loss of 6 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Panagora Asset Management, adding an estimated $24.8K. The largest seller was Sabby Management, exiting entirely with an estimated $89K sold.

  • 4 institutional investors held InspireMD (NSPR) as of Q1 2019, down from 10 in Q4 2018.
  • Funds reported $55K of InspireMD stock for Q1 2019, down 80% quarter-over-quarter.
  • 0 funds opened new InspireMD positions in Q1 2019 and 6 closed out, a net change of -6 holders.
  • The largest InspireMD buyer in Q1 2019 was Panagora Asset Management, an estimated $24.8K added.
  • The largest InspireMD seller in Q1 2019 was Sabby Management, an estimated $89K sold.

Based on aggregated 13F filings for Q1 2019.